Trials / Completed
CompletedNCT04412902
Predictors of Recurrence for High Risk Endometrial Cancer Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 92 (actual)
- Sponsor
- Far Eastern Memorial Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study will analyze whether there is any difference in recurrence and survival rates among the patients who received different adjuvant therapies.
Detailed description
The incidence of endometrial cancer is gradually increasing nowaday. The postoperative treatment of high-risk endometrial cancer is also inconsistent. Besides, the recurrence of high-risk endometrial cancer is high.The investigators retrospective study will analyze the factors associated with recurrence of endometrial cancer, especially for different adjuvant therapies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | adjuvant therapy | Adjuvant chemotherapy and/or radiotherapy |
Timeline
- Start date
- 2020-04-25
- Primary completion
- 2020-10-25
- Completion
- 2020-11-25
- First posted
- 2020-06-02
- Last updated
- 2020-12-09
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04412902. Inclusion in this directory is not an endorsement.